Poly(ε-benzyloxycarbonyl-L-lysine)-grafted branched polyethylenimine as efficient nanocarriers for indomethacin with enhanced oral bioavailability and anti-inflammatory efficacy
Source abstract
Abstract
Star-block copolymers PEI-g-PZLL with a branched polyethylenimine (PEI) core and multiple grafted poly(ε-benzyloxycarbonyl-L-lysine) (PZLL) peripheral chains were designed, synthesized, and evaluated as nanocarriers for indomethacin (IND). In an aqueous solution, PEI-g-PZLL self-assembled into spherical nanoparticles capable of encapsulating IND at high loading capacity and loading efficiency. Differential scanning calorimetry and X-ray diffraction measurements indicated that IND was molecularly or amorphously dispersed in the nanoparticles. Fourier transform infrared spectra revealed the presence of multiple intermolecular interactions, including hydrogen bonding, electrostatic forces, π-π stacking and hydrophobic interactions, between the block copolymer and the IND molecules. IND-loaded nanoparticles exhibited fast release under intestinal pH. Compared with raw IND, the utilization of PEI-g-PZLL as a carrier significantly enhanced the oral bioavailability of IND and improved its protective effect on renal ischemia-reperfusion injury, as evidenced by in vivo pharmacokinetic and pharmacodynamic studies. Cytotoxicity assay, histological observation and cellular uptake study suggested that PEI-g-PZLL was fairly biocompatible. All these results indicated that star-block copolymers PEI-g-PZLL could be used as efficient nanocarriers for IND and other poorly water-soluble drugs. Statement of significance The use of polyethylenimine (PEI) as an oral drug delivery carrier is limited because it is not biodegradable and the use of higher molecular weight PEI leads to improved efficiency but also increased cytotoxicity. The design of functionalized PEIs with low cytotoxicity and high efficiency is crucial for developing a successful oral drug delivery system. In our study, poly(ε-benzyloxycarbonyl-L-lysine) (PZLL)-grafted branched PEI (PEI-g-PZLL) was reported as an oral nanocarrier for indomethacin (IND). The low cytotoxicity and biodegradability, well-defined self-assembled nano-sized polymeric micelles, high loading capacity and loading efficiency, amorphous state of the encapsulated IND, as well as the enhanced oral bioavailability of IND, makes the copolymer PEI-g-PZLL a promising nanocarrier for the oral administration of IND and possibly other poorly water-soluble drugs.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced Polymer Synthesis and Characterization · Hydrogels: synthesis, properties, applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (33)
Show source-provided references
1. Self-assembled pH-sensitive nanoparticles: a platform for oral delivery of protein drugs10.1002/adfm.201001014 ↗
2. Micro/nanofabricated platforms for oral drug delivery10.1016/j.jconrel.2015.07.033 ↗
3. Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs10.2174/138920010791110836 ↗
4. Is nanotechnology a boon for oral drug delivery?10.1016/j.drudis.2014.04.011 ↗
5. Pharmaceutical nanotechnology for oral delivery of anticancer drugs10.1016/j.addr.2012.11.005 ↗
6. Advanced progress of microencapsulation technologies: in vivo and in vitro models for studying oral and transdermal drug deliveries10.1016/j.jconrel.2013.12.028 ↗
7. Impact of nanotechnology on drug delivery10.1021/nn900002m ↗
8. Fate of polymeric nanocarriers for oral drug delivery10.1016/j.cocis.2010.12.005 ↗
9. Nonviral vectors for gene delivery10.1021/cr800409e ↗
10. Polyelectrolyte nanoparticles with high drug loading enhance the oral uptake of hydrophobic compounds10.1021/bm060130l ↗
11. Highly efficient nanomedicines assembled via polymer-drug multiple interactions: tissue-selective delivery carriers10.1016/j.jconrel.2011.03.013 ↗
12. Host-guest interaction mediated polymeric assemblies: multifunctional nanoparticles for drug and gene delivery10.1021/nn901213a ↗
13. Assembled nanomedicines as efficient and safe therapeutics for articular inflammation10.1016/j.ijpharm.2012.09.017 ↗
14. Micellization and reversible pH-sensitive phase transfer of the hyperbranched multiarm PEI-PBLG copolymer10.1002/chem.200501322 ↗
15. Pretreatment with indomethacin protects from acute renal failure following ischemia-reperfusion injury10.1016/S0041-1345(02)03507-8 ↗
16. Pathophysiology of ischaemia-reperfusion injury10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6 ↗
17. A poly(L-lysine)-based hydrophilic star block co-polymer as a protein nanocarrier with facile encapsulation and pH-responsive release10.1016/j.actbio.2012.02.016 ↗
18. Poly(L-lysine)-based star-block copolymers as pH-responsive nanocarriers for anionic drugs10.1016/j.colsurfb.2012.02.034 ↗
19. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects10.1002/jps.24137 ↗
20. Nano-amorphous spray dried powder to improve oral bioavailability of itraconazole10.1016/j.jconrel.2014.06.059 ↗
21. Real-time co-crystal screening and formation between indomethacin and saccharin via DSC analytical technique or DSC-FTIR microspectroscopy10.1007/s10973-014-3787-2 ↗
22. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions10.1023/A:1012167410376 ↗
23. Impact of amorphous and semicrystalline polymers on the dissolution and crystallization inhibition of pioglitazone solid dispersions10.1016/j.powtec.2013.06.039 ↗
24. Conductive polyaniline composite films from aqueous dispersion: performance enhancement by multi-walled carbon nanotube10.1016/j.synthmet.2014.11.007 ↗
25. Controlling diffusion and exchange in layer-by-layer assemblies10.1021/ma061080f ↗
26. Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin10.1016/j.ejpb.2007.09.018 ↗
27. Protective effect of indomethacin in renal ischemia-reperfusion injury in mice10.1631/jzus.B1300196 ↗
28. Selective cyclooxygenase-2 inhibition protects against myocardial din experimental acute ischemia10.1590/S1807-59322009000300016 ↗
29. Effects of the COX-2 inhibitor FK3311 on ischemia - Reperfusion injury in the rat lung10.1080/08941930701365986 ↗
30. The effect of a selective cyclooxygenase-2 inhibitor in extended liver resection with ischemia in dogs10.1006/jsre.2001.6211 ↗
31. Anticytokine therapies for acute inflammation and the systemic inflammatory response syndrome: IL-10 and ischemia/reperfusion injury as a new paradigm10.1097/00024382-200006000-00002 ↗
32. Early release of macrophage migration inhibitory factor after liver ischemia and reperfusion injury in rats10.1016/j.cyto.2011.11.009 ↗
33. Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review10.1007/s00210-007-0183-5 ↗